Xeomin
Active substance: botulinum toxin type A
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · BOTULINUM TOXIN TYPE A 50 [USP'U]/1
United StatesActive
Marketing holder: Merz Pharmaceuticals, LLC
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- BOTULINUM TOXIN TYPE A · 50 [USP'U]/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2b40-77e8-8678-dfcd7883d407,01a1208c-4927-73c1-8784-c8a8b4f1e3ce,01a1208d-59fc-7098-bdf2-87db198fc4b6,01a1208e-4f0d-777a-9bbe-894a028ca6c5,01a1208f-9115-78a6-8db0-f335d75c7b45;count=18 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0259-1605
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAMUSCULAR
Sources
- product · openFDA NDC · 0259-1605 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0259-1605 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0259-1605 · Verified 2026-10-09 · open in source